Jim Simons's position in Adma Biologics is currently worth $6.56 Million. That's 0.01% of their equity portfolio (1128th largest holding). The first Adma Biologics trade was made in Q2 2017. Since then Jim Simons bought shares twelve more times and sold shares on four occasions. The stake costed the investor $2.81 Million, netting the investor a gain of 133% so far.